Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Clinical trial NCT00813046 · COMPLETED

Trial details

NCT number: NCT00813046
Sponsor: BioTech Tools S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Seasonal Allergic Rhinoconjunctivitis

Start date: 2008-12-01
Primary completion: 2009-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.